• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾精神科医生对长效注射用抗精神病药物在不同机构中的偏好差异:一项全国性问卷调查

Discrepancy in Taiwanese psychiatrists' preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey.

作者信息

Liu Chun-Hao, Tsai Po-Hsin, Chen Ching-Yen

机构信息

Department of Psychiatry, Chang Gung Memorial Hospital at Linkou, Taoyuan.

College of Medicine, Chang Gung University, Taoyuan.

出版信息

Neuropsychiatr Dis Treat. 2018 Feb 1;14:429-433. doi: 10.2147/NDT.S154490. eCollection 2018.

DOI:10.2147/NDT.S154490
PMID:29440904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5798540/
Abstract

BACKGROUND

Although many studies have discussed psychiatrists' attitudes toward long-acting injectable antipsychotics (LAIs), no previous study has focused on differences in preference based on the facilities in which the psychiatrists practiced.

MATERIALS AND METHODS

A pilot survey was conducted in a medical center in northern Taiwan, and a questionnaire was then distributed at the annual conference of the Taiwanese Society of Psychiatry in 2013. The questionnaire included general demographic data and preferences for the use of LAIs in different situations.

RESULTS

A total of 142 psychiatrists were included in our study. Among them, 114 were male (80.3%), and most practiced in general hospitals (n=110, 77.5%). We found that general hospital psychiatrists were more likely to prescribe LAIs for patients in the acute stage and with positive symptoms than were psychiatric hospital psychiatrists. General hospital psychiatrists also tended to prescribe LAIs at every time point of the disease.

CONCLUSION

General hospital psychiatrists were more likely to prescribe LAIs than those in psychiatric hospitals. Knowing the factors affecting psychiatrists' preferences may help us to develop a further study to explore "why" psychiatrists consider or do not consider LAIs in different facilities.

摘要

背景

尽管许多研究探讨了精神科医生对长效注射用抗精神病药物(LAIs)的态度,但此前尚无研究关注精神科医生执业机构不同导致的偏好差异。

材料与方法

在台湾北部的一家医疗中心进行了一项初步调查,随后于2013年在台湾精神医学会年会上发放问卷。问卷包括一般人口统计学数据以及在不同情况下使用LAIs的偏好。

结果

我们的研究共纳入142名精神科医生。其中,114名男性(80.3%),大多数在综合医院执业(n = 110,77.5%)。我们发现,与精神病医院的精神科医生相比,综合医院的精神科医生更倾向于为急性期患者及有阳性症状的患者开具LAIs。综合医院的精神科医生在疾病的各个时间点也都倾向于开具LAIs。

结论

综合医院的精神科医生比精神病医院的精神科医生更倾向于开具LAIs。了解影响精神科医生偏好的因素可能有助于我们开展进一步研究,以探究精神科医生在不同机构中考虑或不考虑使用LAIs的“原因”。

相似文献

1
Discrepancy in Taiwanese psychiatrists' preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey.台湾精神科医生对长效注射用抗精神病药物在不同机构中的偏好差异:一项全国性问卷调查
Neuropsychiatr Dis Treat. 2018 Feb 1;14:429-433. doi: 10.2147/NDT.S154490. eCollection 2018.
2
Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan.日本精神分裂症患者对长效注射用抗精神病药物的态度。
Neuropsychiatr Dis Treat. 2019 Jan 9;15:205-211. doi: 10.2147/NDT.S188337. eCollection 2019.
3
Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.口服抗精神病药与长效抗精神病药对社会功能的影响:印度精神科医生的调查。
Asian J Psychiatr. 2017 Dec;30:88-93. doi: 10.1016/j.ajp.2017.08.002. Epub 2017 Aug 9.
4
Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.精神科医生对第一代和第二代抗精神病长效注射剂的使用、知识和态度:5 年的比较。
J Psychopharmacol. 2010 Oct;24(10):1473-82. doi: 10.1177/0269881109104882. Epub 2009 May 28.
5
A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.一项关于长效注射抗精神病药的体验和认知的定性研究:第二部分——医生观点。
Can J Psychiatry. 2013 May;58(5 Suppl 1):23S-9S. doi: 10.1177/088740341305805s04.
6
The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria.尼日利亚精神科医生对抗精神病长效注射剂的知识和态度。
Ther Adv Psychopharmacol. 2012 Oct;2(5):169-77. doi: 10.1177/2045125312453158.
7
Attitudes of Croatian psychiatrists towards long-acting injectable antipsychotics.克罗地亚精神科医生对长效注射用抗精神病药物的态度。
Psychiatr Danub. 2016 Sep;28(3):273-277.
8
A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.一项关于早期干预服务中患者对抗精神病长效注射态度的定性研究。
Ther Adv Psychopharmacol. 2014 Oct;4(5):179-85. doi: 10.1177/2045125314542098.
9
A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.一项关于长效注射抗精神病药物的体验和认知的定性研究:第一部分——患者视角。
Can J Psychiatry. 2013 May;58(5 Suppl 1):14S-22S. doi: 10.1177/088740341305805s03.
10
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia.患者及处方者对长效注射用抗精神病药物的看法以及关于精神分裂症长效注射治疗的门诊讨论分析
BMC Psychiatry. 2013 Oct 16;13:261. doi: 10.1186/1471-244X-13-261.

引用本文的文献

1
Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics.使用长效注射用抗精神病药物或口服抗精神病药物出院的非自愿住院精神分裂症患者再次住院的时间。
Ther Adv Psychopharmacol. 2022 Mar 23;12:20451253221079165. doi: 10.1177/20451253221079165. eCollection 2022.
2
Patients' experiences of long-acting injectable antipsychotics: a qualitative study.长效注射用抗精神病药物的患者体验:一项定性研究。
Neuropsychiatr Dis Treat. 2019 Jul 3;15:1797-1804. doi: 10.2147/NDT.S206154. eCollection 2019.
3
Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics.长效注射抗精神病药或口服抗精神病药治疗的精神分裂症患者再入院时间。
Int J Neuropsychopharmacol. 2019 Sep 1;22(9):541-547. doi: 10.1093/ijnp/pyz035.

本文引用的文献

1
Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoate.长效抗精神病药物在临床实践中的有效性:1. 帕利哌酮棕榈酸酯、利培酮长效注射剂和癸酸珠氯噻醇的回顾性18个月随访及比较
Ther Adv Psychopharmacol. 2016 Feb;6(1):22-32. doi: 10.1177/2045125315623168.
2
Exploring physician specialist response rates to web-based surveys.探索医生专科医生对基于网络的调查的回应率。
BMC Med Res Methodol. 2015 Apr 9;15:32. doi: 10.1186/s12874-015-0016-z.
3
Barriers to utilizing long-acting injectable antipsychotic medications.使用长效注射用抗精神病药物的障碍。
Ann Clin Psychiatry. 2013 Nov;25(4):E1-6.
4
Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.首发精神病患者长效 depot 抗精神病药治疗的患者和临床医生的态度。
Ther Adv Psychopharmacol. 2013 Apr;3(2):89-99. doi: 10.1177/2045125312464106.
5
Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses.长效抗精神病药物给药态度:对医生和护士的调查。
BMC Psychiatry. 2013 Feb 17;13:58. doi: 10.1186/1471-244X-13-58.
6
The pharmacokinetics of long-acting antipsychotic medications.长效抗精神病药物的药代动力学
Curr Clin Pharmacol. 2014;9(3):310-7. doi: 10.2174/15748847113089990051.
7
Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral.精神分裂症患者启用长效注射抗精神病药与口服药物相比的医疗资源使用情况。
J Med Econ. 2013;16(2):231-9. doi: 10.3111/13696998.2012.751025. Epub 2012 Nov 28.
8
Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review.口服与长效注射用抗精神病药物治疗精神分裂症及有治疗不依从风险的特殊人群:一项系统评价
Schizophr Res Treatment. 2012;2012:407171. doi: 10.1155/2012/407171. Epub 2012 Feb 15.
9
Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.评估利培酮长效治疗起始的精神分裂症患者的有效性测量指标:SOURCE 研究结果。
BMC Psychiatry. 2011 Oct 14;11:167. doi: 10.1186/1471-244X-11-167.
10
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.一项全国性队列研究:首发精神分裂症住院后使用口服和长效抗精神病药物。
Am J Psychiatry. 2011 Jun;168(6):603-9. doi: 10.1176/appi.ajp.2011.10081224. Epub 2011 Mar 1.